Carcinoma: all 6,718 studies

Page 17 of 68. Open to participants first (1,141), then studies with results posted, then the rest; newest registration first within each.

• Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 PathwayCompletedNCT02598895Phase 2Results posted
• An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell CarcinomaCompletedNCT02596035Phase 4Results posted
• Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerCompletedNCT02595866Phase 1Results posted
• Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% OintmentCompletedNCT02587819Phase 1Results posted
• Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell CarcinomaTerminatedNCT02584829Phase 1/2Results posted
• NBI to Detect Post-RT Mucosal Residual NPCCompletedNCT02584790Not applicableResults posted
• Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial CancerCompletedNCT02581982Phase 2Results posted
• SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung CancerCompletedNCT02581787Phase 1/2Results posted
• A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) PatientsCompletedNCT02578641Phase 3Results posted
• MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular CarcinomaTerminatedNCT02575339Phase 1/2Results posted
• Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)CompletedNCT02573493Phase 2Results posted
• A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsCompletedNCT02573259Phase 1Results posted
• Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerTerminatedNCT02569957Phase 2Results posted
• Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial CancerCompletedNCT02567409Phase 2Results posted
• Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate CancerTerminatedNCT02565901Phase 1/2Results posted
• Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/ Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)CompletedNCT02564263Phase 3Results posted
• Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177)CompletedNCT02563002Phase 3Results posted
• Trial of TRC105 and Sorafenib in Patients With HCCCompletedNCT02560779Phase 1/2Results posted
• Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)CompletedNCT02559687Phase 2Results posted
• 11C-acetate for Treatment Response After Radiotherapy for HCCTerminatedNCT02549755Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney CancerTerminatedNCT02542202Not applicableResults posted
• Trial Using Gilotrif for Advanced Penile Squamous Cell CarcinomaTerminatedNCT02541903Phase 2Results posted
• A Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantTerminatedNCT02540330Phase 2Results posted
• Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by SurgeryCompletedNCT02538510Phase 1/2Results posted
• An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American ParticipantsCompletedNCT02535026Results posted
• A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT02528643Phase 2Results posted
• Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After SurgeryCompletedNCT02526498Phase 2Results posted
• Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT02524275Phase 2Results posted
• LEE001 and Chemoembolization In Patients With Advanced Hepatocellular CarcinomaTerminatedNCT02524119Phase 2Results posted
• A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaTerminatedNCT02521870Phase 1/2Results posted
• Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by SurgeryCompletedNCT02520141Phase 2Results posted
• MLN0128 in Recurrent/Metastatic Merkel Cell CarcinomaCompletedNCT02514824Phase 1/2Results posted
• Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular CarcinomaCompletedNCT02513199Phase 2Results posted
• Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver MetastasesCompletedNCT02511522Not applicableResults posted
• Preoperative Olaparib Endometrial Carcinoma Study (POLEN)CompletedNCT02506816Results posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaTerminatedNCT02504099Phase 3Results posted
• Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate CancerCompletedNCT02499835Phase 1/2Results posted
• Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck CancerCompletedNCT02499120Phase 2Results posted
• Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell CarcinomaTerminatedNCT02495103Phase 1/2Results posted
• RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)CompletedNCT02489903Phase 2Results posted
• Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell CancersCompletedNCT02487095Phase 1/2Results posted
• QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)TerminatedNCT02465957Phase 2Results posted
• A Study of ONCO-DOX in Locally Advanced Hepatocellular CarcinomaTerminatedNCT02460991Phase 3Results posted
• A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular CarcinomaCompletedNCT02460835Not applicableResults posted
• Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164)CompletedNCT02460198Phase 2Results posted
• Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot InitiativeCompletedNCT02456857Phase 2Results posted
• Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)CompletedNCT02454478Phase 1Results posted
• Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT02454179Phase 2Results posted
• Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapyTerminatedNCT02452463Phase 2Results posted
• Neoadjuvant Atezolizumab in Localized Bladder CancerCompletedNCT02451423Phase 2Results posted
• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical ResectionTerminatedNCT02450331Phase 3Results posted
• Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT02448303Phase 2Results posted
• Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)TerminatedNCT02447887Phase 1/2Results posted
• A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerCompletedNCT02443324Phase 1Results posted
• Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following CryoablationCompletedNCT02440334Phase 2Results posted
• VISmodegib for ORbital and Periocular Basal Cell CarcinomaCompletedNCT02436408Phase 4Results posted
• Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)CompletedNCT02432846Phase 2Results posted
• A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial CancerCompletedNCT02426125Phase 3Results posted
• Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response EvaluationCompletedNCT02424955Not applicableResults posted
• A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaCompletedNCT02423343Phase 1/2Results posted
• A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)CompletedNCT02420821Phase 3Results posted
• Sapanisertib in Treating Patients With Stage IV or Recurrent Lung CancerCompletedNCT02417701Phase 2Results posted
• Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)CompletedNCT02414139Phase 2Results posted
• Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract CancerCompletedNCT02412670Phase 2Results posted
• Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell CarcinomaTerminatedNCT02401542Phase 1/2Results posted
• Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung CancerCompletedNCT02394548Not applicableResults posted
• Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal CancerCompletedNCT02393755Phase 1/2Results posted
• Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid CancerCompletedNCT02393690Phase 2Results posted
• Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary CancersCompletedNCT02392637Phase 2Results posted
• MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase CTerminatedNCT02391038Phase 1Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck CancerTerminatedNCT02388932Not applicableResults posted
• Intraoperative Radiotherapy After Local Recurrence in Breast CancerCompletedNCT02386371Not applicableResults posted
• Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck CancerCompletedNCT02383966Phase 3Results posted
• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsCompletedNCT02383927Phase 2Results posted
• Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck CancerCompletedNCT02369874Phase 3Results posted
• CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI)TerminatedNCT02365714Phase 1/2Results posted
• Pembrolizumab and Epacadostat in Patients With Thymic CarcinomaStatus unknownNCT02364076Phase 2Results posted
• Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder CancerCompletedNCT02351739Phase 2Results posted
• Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:CompletedNCT02348008Phase 1/2Results posted
• Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck CancerCompletedNCT02347332Phase 3Results posted
• Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)TerminatedNCT02345330Phase 2Results posted
• Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal CancerCompletedNCT02339558Phase 2Results posted
• Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCompletedNCT02337946Phase 2Results posted
• KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic CancerCompletedNCT02337465Not applicableResults posted
• Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)CompletedNCT02329860Phase 3Results posted
• FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB ExpressionCompletedNCT02325739Phase 1/2Results posted
• Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin CancerCompletedNCT02324608Not applicableResults posted
• Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and NeckCompletedNCT02319044Phase 2Results posted
• Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCCCompletedNCT02315755Results posted
• Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive SurgeryTerminatedNCT02315625Phase 2Results posted
• Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02315430Phase 2Results posted
• Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyCompletedNCT02314156Phase 2Results posted
• Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular CarcinomaTerminatedNCT02314052Phase 1/2Results posted
• Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell CarcinomaTerminatedNCT02303041Phase 2Results posted
• Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder CancerCompletedNCT02300610Phase 1Results posted
• Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and NeckCompletedNCT02289209Phase 2Results posted
• Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT02283658Phase 2Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• Dose Finding Safety Study of VAL201 in Cancer PatientsCompletedNCT02280317Phase 1/2Results posted
• A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular CarcinomaCompletedNCT02279719Phase 1/2Results posted

← Carcinoma overview